Neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan
MONDO:0018282Also known as: alpha-dystroglycanopathy, dystroglycanopathy, qualitative or quantitative defects of alpha-dystroglycan
8 clinical trials for this condition and its sub-types, 0 tagged with Neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan
-
Qualitative or quantitative defects of protein involved in O-glycosylation of alpha-dystroglycan 0 trials · 8 incl. sub-types
9 sub-types
- Qualitative or quantitative defects of FKRP 0 trials · 8 incl. sub-types Sub-types →
- Myopathy caused by variation in FKTN 1 trial · 2 incl. sub-types Sub-types →
- Myopathy caused by variation in CRPPA 0 trials · 1 incl. sub-types Sub-types →
- Myopathy caused by variation in GMPPB 0 trials · 1 incl. sub-types Sub-types →
- Myopathy caused by variation in POMT1 0 trials · 1 incl. sub-types Sub-types →
- Myopathy caused by variation in POMT2 0 trials · 1 incl. sub-types Sub-types →
- Qualitative or quantitative defects of protein O-mannosyltransferase 1 0 trials · 1 incl. sub-types Sub-types →
- Qualitative or quantitative defects of protein O-mannosyltransferase 2 0 trials · 1 incl. sub-types Sub-types →
- Limb-girdle muscular dystrophy due to POMK deficiency 0 trials
Most studied deeper sub-types
We haven't found any trials for this condition yet. Follow it to get notified when new trials appear.